---
schema_version: "secwatch.filing_event.v1"
accession: "0001789769-22-000077"
form_type: "8-K"
ticker: "TIL"
cik: "0001789769"
company_name: "Instil Bio, Inc."
filed_at: "2022-09-06T23:59:59+00:00"
generated_at: "2026-06-23T15:36:37.151139+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Instil Bio appoints Tim Moore as COO, CTO Vijay Chiruvolu resigns

## Summary
- Tim Moore appointed COO effective Sept 6, 2022; previously President/COO at PACT Pharma and EVP at Kite.
- Moore receives $565K base salary, $100K signing bonus, 50% target bonus, and 750,000 stock option grant.
- Separately, CTO Vijay Chiruvolu resigned on Sept 2, 2022; terms not disclosed.
- Moore brings cell therapy manufacturing experience, including launch of Yescarta at Kite.

## SEC filing metadata
- accession: 0001789769-22-000077
- form_type: 8-K
- ticker: TIL
- cik: 0001789769
- company_name: Instil Bio, Inc.
- filed_at: 2022-09-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1789769/000178976922000077/0001789769-22-000077-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1789769/000178976922000077/til-20220902.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001789769-22-000077
- JSON: https://secwatch.observer/filing/0001789769-22-000077.json
- Plain text: https://secwatch.observer/filing/0001789769-22-000077.txt

## Key facts
- Executive change
  Timothy L. Moore was appointed as Chief Operating Officer at Instil Bio, Inc..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On September 6, 2022 (the “Effective Date”), the board of directors (the “Board”) of Instil Bio, Inc. (the “Company”) appointed Timothy L. Moore as Chief Operating Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1789769/000178976922000077/0001789769-22-000077-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.